Bortezomib Booms For Stada As Russian Problem Remains
Turnaround Strategy Is In The Works In Russia
With group sales rising by double digits in 2019, Stada says it has the firepower to accelerate investment not only in the firm’s own product development but also broadly into external co-development and product in-licensing, to support sustainability and long-term growth.
